587 related articles for article (PubMed ID: 18602831)
21. Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivatives.
Zou HB; Dong SY; Zhou CX; Hu LH; Wu YH; Li HB; Gong JX; Sun LL; Wu XM; Bai H; Fan BT; Hao XJ; Stöckigt J; Zhao Y
Bioorg Med Chem; 2006 Mar; 14(6):2060-71. PubMed ID: 16303311
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases.
Yamali C; Gul HI; Sakagami H; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup4):125-131. PubMed ID: 27594305
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
[TBL] [Abstract][Full Text] [Related]
24. Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents.
Won SJ; Liu CT; Tsao LT; Weng JR; Ko HH; Wang JP; Lin CN
Eur J Med Chem; 2005 Jan; 40(1):103-12. PubMed ID: 15642415
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells.
Nagaraju M; Gnana Deepthi E; Ashwini C; Vishnuvardhan MV; Lakshma Nayak V; Chandra R; Ramakrishna S; Gawali BB
Bioorg Med Chem Lett; 2012 Jul; 22(13):4314-7. PubMed ID: 22668451
[TBL] [Abstract][Full Text] [Related]
26. Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia.
Montes-Avila J; Díaz-Camacho SP; Sicairos-Félix J; Delgado-Vargas F; Rivero IA
Bioorg Med Chem; 2009 Sep; 17(18):6780-5. PubMed ID: 19683930
[TBL] [Abstract][Full Text] [Related]
27. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
Cabrera M; Simoens M; Falchi G; Lavaggi ML; Piro OE; Castellano EE; Vidal A; Azqueta A; Monge A; de Ceráin AL; Sagrera G; Seoane G; Cerecetto H; González M
Bioorg Med Chem; 2007 May; 15(10):3356-67. PubMed ID: 17383189
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives.
Issa S; Walchshofer N; Kassab I; Termoss H; Chamat S; Geahchan A; Bouaziz Z
Eur J Med Chem; 2010 Jun; 45(6):2567-77. PubMed ID: 20236739
[TBL] [Abstract][Full Text] [Related]
30. Structural requirement of chalcones for the inhibitory activity of interleukin-5.
Yang HM; Shin HR; Cho SH; Bang SC; Song GY; Ju JH; Kim MK; Lee SH; Ryu JC; Kim Y; Jung SH
Bioorg Med Chem; 2007 Jan; 15(1):104-11. PubMed ID: 17064909
[TBL] [Abstract][Full Text] [Related]
31. Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities.
de Carvalho Tavares L; Johann S; Maria de Almeida Alves T; Guerra JC; Maria de Souza-Fagundes E; Cisalpino PS; Bortoluzzi AJ; Caramori GF; de Mattos Piccoli R; Braibante HT; Braibante ME; Pizzolatti MG
Eur J Med Chem; 2011 Sep; 46(9):4448-56. PubMed ID: 21816519
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
33. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
Dong X; Chen J; Jiang C; Liu T; Hu Y
Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479
[TBL] [Abstract][Full Text] [Related]
35. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
36. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
[TBL] [Abstract][Full Text] [Related]
37. Anticancer activities of novel chalcone and bis-chalcone derivatives.
Modzelewska A; Pettit C; Achanta G; Davidson NE; Huang P; Khan SR
Bioorg Med Chem; 2006 May; 14(10):3491-5. PubMed ID: 16434201
[TBL] [Abstract][Full Text] [Related]
38. Design and one-pot synthesis of new 7-acyl camptothecin derivatives as potent cytotoxic agents.
Liu YQ; Dai W; Wang CY; Morris-Natschke SL; Zhou XW; Yang L; Yang XM; Li WQ; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7659-61. PubMed ID: 23102893
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
40. Pt(II) complexes of a combretastatin A-4 analogous chalcone: effects of conjugation on cytotoxicity, tumor specificity, and long-term tumor growth suppression.
Schobert R; Biersack B; Dietrich A; Knauer S; Zoldakova M; Fruehauf A; Mueller T
J Med Chem; 2009 Jan; 52(2):241-6. PubMed ID: 19102652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
